A. N. Ikhambayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. N. Ikhambayeva has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
M. E. Bikhert
Department of Clinical Pharmacology of NСJSC «Astana Medical University
2 shared publicationsN. S. Akhmadyar
Department of Clinical Pharmacology of NСJSC «Astana Medical University
2 shared publicationsR. E. Akhmediya
Department of Clinical Pharmacology of NСJSC «Astana Medical University
2 shared publicationsSh. K. Koshayeva
Department of Clinical Pharmacology of NСJSC «Astana Medical University
2 shared publications- Elizaveta Tentiuc
Pharmacovigilance Department, Medicines and Medical Devices Agency, 2/1 Korolenko str, Chisinau, 2028, Republic of Moldova
1 shared publication - Gaukhar Zhetimkarinova
Department of Clinical Pharmacy, National Research Center for Maternal and Child Health, Astana, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 30 December 2024
- Published by Karaganda Medical University in Medicine and Ecology
- No. 4,p. 107-123
Aspects of improving clinical protocols for the profile «Adult urology»
Aim of the study. To evaluate the availability of pharmacological treatment and the relevance of recommendations presented in clinical protocols in the field of «Adult Urology» through a comparative analysis of international experience and to identify aspects for improving protocols in this field.Materials and methods. The materials used were current clinical protocols for diagnosis and treatment in the field of «Adult Urology» available on the official website of the National Scientific Center for Healthcare Development, international recommendations of the constantly updated database of guidelines for decision support in clinical practice British Medical Journal Best Practice, guidelines of the European Association of Urologists, guidelines, reviews of the UpToDate resource, providing medical professionals with relevant and evidence-based information.Results and discussion. Urological diseases are often complex, multifactorial conditions; it is impossible to encompass all treatment regimens for every clinical scenario. Nonetheless, it is necessary to broaden the scope of this profile by developing clinical protocols depending on the etiological factor, extent of involvement, and stage of medical intervention. Upon reviewing clinical protocols in the field of «Adult Urology» the following common deviations were identified regarding pharmacotherapy: irrational selection of antibacterial agents, routine use of antifungal prophylaxis, use of medications with low levels of evidence, dosing regimen errors, and the use of trade names in the protocol text, which constitutes a blatant violation of the ethical promotion policy of pharmaceuticals. Antibiotic therapy is recommended only for confirmed bacteriuria with broadspectrum antibiotics. Antifungal prophylaxis is recommended only for patients at risk (secondary or primary immunodeficiency).Conclusions. Currently, 100% of clinical protocols in the field of «Adult Urology» are outdated and require revision. The rapid advancement of science, development, and improvement of pharmaceuticals necessitates ongoing professional development on the part of healthcare personnel, which can be facilitated by regular updating of clinical protocols. The availability of pharmacological therapy for urological patients is quite high: 97.35% medications presented in clinical protocols are available to patients in the Kazakhstani market (registered and included in the Kazakhstani National Drug Formulary), 94.7% medications are reimbursed within the framework of outpatient care, and 90.9% medications are available for procurement by medical organizations through the Single Distributor.
- 30 December 2024
- Published by Karaganda Medical University in Medicine and Ecology
- No. 4,p. 107-123
Open AccessAspects of improving clinical protocols for the profile «Adult urology»
Aim of the study. To evaluate the availability of pharmacological treatment and the relevance of recommendations presented in clinical protocols in the field of «Adult Urology» through a comparative analysis of international experience and to identify aspects for improving protocols in this field.Materials and methods. The materials used were current clinical protocols for diagnosis and treatment in the field of «Adult Urology» available on the official website of the National Scientific Center for Healthcare Development, international recommendations of the constantly updated database of guidelines for decision support in clinical practice British Medical Journal Best Practice, guidelines of the European Association of Urologists, guidelines, reviews of the UpToDate resource, providing medical professionals with relevant and evidence-based information.Results and discussion. Urological diseases are often complex, multifactorial conditions; it is impossible to encompass all treatment regimens for every clinical scenario. Nonetheless, it is necessary to broaden the scope of this profile by developing clinical protocols depending on the etiological factor, extent of involvement, and stage of medical intervention. Upon reviewing clinical protocols in the field of «Adult Urology» the following common deviations were identified regarding pharmacotherapy: irrational selection of antibacterial agents, routine use of antifungal prophylaxis, use of medications with low levels of evidence, dosing regimen errors, and the use of trade names in the protocol text, which constitutes a blatant violation of the ethical promotion policy of pharmaceuticals. Antibiotic therapy is recommended only for confirmed bacteriuria with broadspectrum antibiotics. Antifungal prophylaxis is recommended only for patients at risk (secondary or primary immunodeficiency).Conclusions. Currently, 100% of clinical protocols in the field of «Adult Urology» are outdated and require revision. The rapid advancement of science, development, and improvement of pharmaceuticals necessitates ongoing professional development on the part of healthcare personnel, which can be facilitated by regular updating of clinical protocols. The availability of pharmacological therapy for urological patients is quite high: 97.35% medications presented in clinical protocols are available to patients in the Kazakhstani market (registered and included in the Kazakhstani National Drug Formulary), 94.7% medications are reimbursed within the framework of outpatient care, and 90.9% medications are available for procurement by medical organizations through the Single Distributor.
- Open Access
- 26 October 2024
- Published by Karaganda Medical University in Medicine and Ecology
- No. 3,p. 105-112
Non-steroid anti-inflammatory drugs: recommendations and precautions for safe use in a multidisciplinary surgical department
Aim of the study. Conducting a safety analysis of the use of non-steroidal anti-inflammatory drugs in order to develop informed recommendations and precautions for medical practice.Materials and methods. A retrospective analysis of inpatient medical records of 250 patients in the multidisciplinary surgery department was conducted for the period from December 2023 to February 2024.Results and discussion. Based on the results of the analysis of inpatient medical records, such criteria as the presence of indications for the prescription of non-steroidal anti-inflammatory drugs (according to the diagnosis, clinical pain syndrome and according to pain assessment scales), compliance of the choice of non-steroidal anti-inflammatory drugs with national protocols/international recommendations, compliance with age, the patient's physiological/ pathological condition and allergy history for the prescription of non-steroidal anti-inflammatory drugs were 100%. The indicator for compliance of a single therapeutic dose, route of administration, frequency, duration and an appropriate diluent of non-steroidal anti-inflammatory drugs with instructions for use was 86%, where medication errors were mainly made in the frequency of use of drugs. The percentage of polypharmacy was 20%. The criterion for assessing drug-drug interactions between drugs taken by patients showed that interactions of high clinical significance (major) were 8%, while those of moderate clinical significance (moderate) were 40%.Conclusions. Nonsteroidal anti-inflammatory drugs are convenient and affordable drugs that are widely used in the treatment of diseases of various organs and systems. Therefore, to ensure the rational and safe use of drugs in this group, it is necessary to introduce effective recommendations and precautions:1. Timely completion of pain assessment scales and diary records in the Damumed medical information system;2. Development in the Damumed medical information system of divisions of appointments into planned and pro re nata (as necessary), introduction into the system of accurately recording the time of execution of doctors’ prescriptions by nursing staff for strict compliance with the intervals between doses of non-steroidal anti-inflammatory drugs allowed by the instructions.3. Introduction into the practice of doctors the use of tools to combat polypharmacy in patients ≥65 years old: Beers criteria;4. Conducting educational activities, covering both medical personnel and patients, in order to increase the level of registration of unwanted adverse reactions.
- 26 October 2024
- Published by Karaganda Medical University in Medicine and Ecology
- No. 3,p. 105-112
Open AccessNon-steroid anti-inflammatory drugs: recommendations and precautions for safe use in a multidisciplinary surgical department
Aim of the study. Conducting a safety analysis of the use of non-steroidal anti-inflammatory drugs in order to develop informed recommendations and precautions for medical practice.Materials and methods. A retrospective analysis of inpatient medical records of 250 patients in the multidisciplinary surgery department was conducted for the period from December 2023 to February 2024.Results and discussion. Based on the results of the analysis of inpatient medical records, such criteria as the presence of indications for the prescription of non-steroidal anti-inflammatory drugs (according to the diagnosis, clinical pain syndrome and according to pain assessment scales), compliance of the choice of non-steroidal anti-inflammatory drugs with national protocols/international recommendations, compliance with age, the patient's physiological/ pathological condition and allergy history for the prescription of non-steroidal anti-inflammatory drugs were 100%. The indicator for compliance of a single therapeutic dose, route of administration, frequency, duration and an appropriate diluent of non-steroidal anti-inflammatory drugs with instructions for use was 86%, where medication errors were mainly made in the frequency of use of drugs. The percentage of polypharmacy was 20%. The criterion for assessing drug-drug interactions between drugs taken by patients showed that interactions of high clinical significance (major) were 8%, while those of moderate clinical significance (moderate) were 40%.Conclusions. Nonsteroidal anti-inflammatory drugs are convenient and affordable drugs that are widely used in the treatment of diseases of various organs and systems. Therefore, to ensure the rational and safe use of drugs in this group, it is necessary to introduce effective recommendations and precautions:1. Timely completion of pain assessment scales and diary records in the Damumed medical information system;2. Development in the Damumed medical information system of divisions of appointments into planned and pro re nata (as necessary), introduction into the system of accurately recording the time of execution of doctors’ prescriptions by nursing staff for strict compliance with the intervals between doses of non-steroidal anti-inflammatory drugs allowed by the instructions.3. Introduction into the practice of doctors the use of tools to combat polypharmacy in patients ≥65 years old: Beers criteria;4. Conducting educational activities, covering both medical personnel and patients, in order to increase the level of registration of unwanted adverse reactions.
- 1 February 2020
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 16 (2) , 238-248
The antibiotic knowledge, attitudes and behaviors of patients, doctors and pharmacists in the WHO Eastern European region – a qualitative, comparative analysis of the culture of antibiotic use in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajikistan
- 1 February 2020
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 16 (2) , 238-248
The antibiotic knowledge, attitudes and behaviors of patients, doctors and pharmacists in the WHO Eastern European region – a qualitative, comparative analysis of the culture of antibiotic use in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajikistan